Literature DB >> 30922125

Adipose glucocorticoid action influences whole-body metabolism via modulation of hepatic insulin action.

Abudukadier Abulizi1, João-Paulo Camporez1, Michael J Jurczak1, Kasper F Høyer1,2, Dongyan Zhang3, Gary W Cline1, Varman T Samuel1,4, Gerald I Shulman1,3,5, Daniel F Vatner1.   

Abstract

The connection between adipose glucocorticoid action and whole-body metabolism is incompletely understood. Thus, we generated adipose tissue-specific glucocorticoid receptor-knockout (Ad-GcR-/-) mice to explore potential mechanisms. Ad-GcR-/- mice had a lower concentration of fasting plasma nonesterified fatty acids and less hepatic steatosis. This was associated with increased protein kinase B phosphorylation and increased hepatic glycogen synthesis after an oral glucose challenge. High-fat diet (HFD)-fed Ad-GcR-/- mice were protected against the development of hepatic steatosis and diacylglycerol-PKCε-induced impairments in hepatic insulin signaling. Under hyperinsulinemic-euglycemic conditions, hepatic insulin response was ∼10-fold higher in HFD-fed Ad-GcR-/- mice. Insulin-mediated suppression of adipose lipolysis was improved by 40% in Ad-GcR-/- mice. Adipose triglyceride lipase expression was decreased and insulin-mediated perilipin dephosphorylation was increased in Ad-GcR-/- mice. In metabolic cages, food intake decreased by 3 kcal/kg per hour in Ad-GcR-/- mice. Therefore, physiologic adipose glucocorticoid action appears to drive hepatic lipid accumulation during stressors such as fasting. The resultant hepatic insulin resistance prevents hepatic glycogen synthesis, preserving glucose for glucose-dependent organs. Absence of adipose glucocorticoid action attenuates HFD-induced hepatic insulin resistance; potential explanations for reduction in hepatic steatosis include reductions in adipose lipolysis and food intake.-Abulizi, A., Camporez, J.-P., Jurczak, M. J., Høyer, K. F., Zhang, D., Cline, G. W., Samuel, V. T., Shulman, G. I., Vatner, D. F. Adipose glucocorticoid action influences whole-body metabolism via modulation of hepatic insulin action.

Entities:  

Keywords:  glycogen synthesis; hepatic steatosis; insulin resistance; white adipose tissue

Mesh:

Substances:

Year:  2019        PMID: 30922125      PMCID: PMC6593882          DOI: 10.1096/fj.201802706R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  54 in total

Review 1.  Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action.

Authors:  J R Seckl; B R Walker
Journal:  Endocrinology       Date:  2001-04       Impact factor: 4.736

2.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

3.  Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells.

Authors:  Jerome Galon; Denis Franchimont; Naoki Hiroi; Gregory Frey; Antje Boettner; Monika Ehrhart-Bornstein; John J O'Shea; George P Chrousos; Stefan R Bornstein
Journal:  FASEB J       Date:  2002-01       Impact factor: 5.191

4.  Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle.

Authors:  Chunli Yu; Yan Chen; Gary W Cline; Dongyan Zhang; Haihong Zong; Yanlin Wang; Raynald Bergeron; Jason K Kim; Samuel W Cushman; Gregory J Cooney; Bronwyn Atcheson; Morris F White; Edward W Kraegen; Gerald I Shulman
Journal:  J Biol Chem       Date:  2002-11-14       Impact factor: 5.157

5.  A transgenic model of visceral obesity and the metabolic syndrome.

Authors:  H Masuzaki; J Paterson; H Shinyama; N M Morton; J J Mullins; J R Seckl; J S Flier
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

6.  Tissue and isoform-selective activation of protein kinase C in insulin-resistant obese Zucker rats - effects of feeding.

Authors:  X Qu; J P Seale; R Donnelly
Journal:  J Endocrinol       Date:  1999-08       Impact factor: 4.286

Review 7.  Regulation of leptin production in humans.

Authors:  S K Fried; M R Ricci; C D Russell; B Laferrère
Journal:  J Nutr       Date:  2000-12       Impact factor: 4.798

8.  Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue.

Authors:  Jens M Bruun; Aina S Lihn; Atul K Madan; Steen B Pedersen; Kirsten M Schiøtt; John N Fain; Bjørn Richelsen
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-09-16       Impact factor: 4.310

Review 9.  Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis.

Authors:  Fredric B Kraemer; Wen-Jun Shen
Journal:  J Lipid Res       Date:  2002-10       Impact factor: 5.922

10.  Effects of glucocorticoids on leptin levels and eating behaviour in women.

Authors:  J Uddén; P Björntorp; P Arner; B Barkeling; L Meurling; S Rössner
Journal:  J Intern Med       Date:  2003-02       Impact factor: 8.989

View more
  8 in total

1.  The glucocorticoid receptor in brown adipocytes is dispensable for control of energy homeostasis.

Authors:  Christina Glantschnig; Frits Mattijssen; Elena Sophie Vogl; Asrar Ali Khan; Marcos Rios Garcia; Katrin Fischer; Timo Müller; Henriette Uhlenhaut; Peter Nawroth; Marcel Scheideler; Adam J Rose; Natalia Pellegata; Stephan Herzig
Journal:  EMBO Rep       Date:  2019-09-26       Impact factor: 8.807

2.  Hepatic miR-192-3p reactivation alleviates steatosis by targeting glucocorticoid receptor.

Authors:  Zhangting Wang; Kai-Kei Miu; Xueyan Zhang; Angel Tsz-Yau Wan; Gang Lu; Hoi-Hung Cheung; Heung-Man Lee; Alice Pik-Shan Kong; Juliana Chung-Ngor Chan; Wai-Yee Chan
Journal:  JHEP Rep       Date:  2020-09-06

Review 3.  The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD.

Authors:  Ting Hong; Yiyan Chen; Xiaoying Li; Yan Lu
Journal:  Oxid Med Cell Longev       Date:  2021-10-27       Impact factor: 6.543

Review 4.  The long winding road to the safer glucocorticoid receptor (GR) targeting therapies.

Authors:  Ekaterina A Lesovaya; Daria Chudakova; Gleb Baida; Ekaterina M Zhidkova; Kirill I Kirsanov; Marianna G Yakubovskaya; Irina V Budunova
Journal:  Oncotarget       Date:  2022-02-18

5.  Positive association of nap duration with risk of non-alcoholic fatty liver disease in an occupational population in Guangdong Province, China: a cross-sectional study.

Authors:  Chang Hong; Chengkai Wu; Pengcheng Ma; Hao Cui; Liya Chen; Ruining Li; Qimei Li; Lin Zeng; Shengwu Liao; Lushan Xiao; Li Liu; Wenyuan Li
Journal:  BMC Gastroenterol       Date:  2022-04-12       Impact factor: 3.067

6.  Comparative Analysis of Metabolite Profiling of Momordica charantia Leaf and the Anti-Obesity Effect through Regulating Lipid Metabolism.

Authors:  Meiqi Fan; Jae-In Lee; Young-Bae Ryu; Young-Jin Choi; Yujiao Tang; Mirae Oh; Sang-Ho Moon; Bokyung Lee; Eun-Kyung Kim
Journal:  Int J Environ Res Public Health       Date:  2021-05-24       Impact factor: 3.390

7.  Thyroid-Stimulating Hormone Inhibits Insulin Receptor Substrate-1 Expression and Tyrosyl Phosphorylation in 3T3-L1 Adipocytes by Increasing NF-κB DNA-Binding Activity.

Authors:  Yajing Zhang; Ling Feng
Journal:  Dis Markers       Date:  2022-03-14       Impact factor: 3.434

Review 8.  Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease.

Authors:  Yang Xiao; Mindy Kim; Mitchell A Lazar
Journal:  Mol Metab       Date:  2020-11-18       Impact factor: 7.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.